Neuren Pharmaceuticals reported AUD0.12 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
0.04 32.00 0.12 Aug/25




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
Avita Medical AUD -0.25 0.13 Jun/2026
Clinuvel Pharmaceuticals AUD 0.21 0.23 Dec/2025
Dianthus Therapeutics USD -0.9 0.05 Jun/2026
Genetic Signatures AUD -0.03 0.02 Dec/2025
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
Medical Developments International AUD 0 0 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organon & Co USD 0.64 0.24 Sep/2026
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Starpharma Holdings AUD 0 0.01 Dec/2025
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
Telix Pharmaceuticals AUD 0.1 0.16 Jun/2026
Viatris USD 0.71 0.02 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026